An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to contact these accounts privately for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.
Some professionals stated the popularity for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or prison.
Platform Reaction and Material Removal
Based on the social media company, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The organization said it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Trading Activities
Research also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, glowing testimonials and detailed guides for preparing or injecting at home.
Within minutes of entering one group, a vendor posted contact information, where most transactions occur. The seller sent an guidebook and promised shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.
Item Details and Pricing
Within these communities, messages show dark colored packages with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram stated it actively moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has previously seen patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to potentially serious medical dangers”.
